Trademark: 76494914
Word
RELZIQ
Status
Dead
Status Code
606
Status Date
Friday, January 14, 2005
Serial Number
76494914
Mark Type
1000
Filing Date
Thursday, March 6, 2003
Published for Opposition
Tuesday, October 21, 2003
Abandoned Date
Friday, January 14, 2005

Trademark Owner History
Eli Lilly and Company - Owner At Publication

Classifications
5 pharmaceutical and medicinal preparations for the treatment and prevention of blood disorders, cancer/oncology, cardiovascular diseases, central nervous systems diseases and disorders, dermatological disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases, macular degeneration, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, and urological disorders
The mark "RELZIQ" is a coined, non-dictionary, non-foreign word with no English translation.

Trademark Events
May 8, 2005
Abandonment Notice Mailed - No Use Statement Filed
May 6, 2005
Abandonment - No Use Statement Filed
Jun 14, 2004
Extension 1 Granted
Jun 3, 2004
Extension 1 Filed
Jun 3, 2004
Teas Extension Received
Jan 13, 2004
Noa Mailed - Sou Required From Applicant
Oct 21, 2003
Published For Opposition
Oct 1, 2003
Notice Of Publication
Aug 14, 2003
Approved For Pub - Principal Register
Aug 14, 2003
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24